Adding evolocumab to standard lipid-lowering therapy for hypertriglyceridemia-induced acute pancreatitis
Treatments studied
Part of Digestive system, Hormones & metabolism clinical trials.
This trial tests if adding a medication called evolocumab to usual cholesterol-lowering treatment helps people who have had a specific type of pancreatitis caused by very high triglycerides (a type of fat in the blood). It aims to reduce triglyceride levels and prevent another episode.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have had acute pancreatitis (inflammation of the pancreas) caused by very high triglycerides.
- You have mixed hyperlipidemia (high levels of fats in your blood).
- You have not taken any cholesterol-lowering drugs or undergone blood purification in the past week.
- You have not used evolocumab in the past month.
- You are not pregnant or breastfeeding, and do not have serious health conditions that could affect your survival.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medication (a GLP-1 agonist) to see if it can prevent another pancreatitis attack caused by very high triglycerides. If you recently had such an attack, this treatment might lower your risk of it happening again.
This study looks at people with acute pancreatitis caused by very high blood fat levels (triglycerides). It aims to collect information to better understand and treat this condition.
This trial tests if adding a probiotic (Bacillus subtilis and Enterococcus faecium) to standard lipid-lowering therapy helps people with mild pancreatitis caused by very high triglycerides. It aims to see if the combination reduces inflammation and speeds recovery.
This Phase 1 trial tests the safety of a gene therapy for people with inherited, hard-to-control high triglycerides (fat in the blood) who have had pancreatitis episodes. It may help by targeting the genes involved in triglyceride control, but the main goal here is to check safety and tolerability.
This trial is studying whether stopping alcohol and quitting smoking can help keep acute pancreatitis from returning. It’s for people whose pancreatitis happened because of alcohol, and who smoke every day.
This study tests an investigational medication called DR10624 for people with very high triglycerides, a type of fat in the blood that can increase the risk of heart problems and pancreatitis. The trial aims to see if this drug can safely lower triglycerides better than standard care.
Hear when a new Hypertriglyceridemia Induced Acute Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.